These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 4641625)

  • 1. Inhibition of plasminogen activators by naturally occurring inhibitors in man.
    Aoki N; Kawano T
    Am J Physiol; 1972 Dec; 223(6):1334-7. PubMed ID: 4641625
    [No Abstract]   [Full Text] [Related]  

  • 2. [Molecular mechanisms of fibrinolysis and perspectives of thrombolytic therapy].
    Veremeenko KN; Kizim AI
    Vopr Med Khim; 1984; 30(5):13-22. PubMed ID: 6084892
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Mechanisms of fibrilolysis activation and fibrinolysis inhibition].
    Haas S; Wriedt-Lübbe I; Blümel G
    Med Welt; 1978 Feb; 29(6):209-11. PubMed ID: 340843
    [No Abstract]   [Full Text] [Related]  

  • 4. Biphasic inhibition of urokinase-induced fibrinolysis by epsilon-aminocaproic acid; distinction from tissue plasminogen activator.
    Thorsen S; Astrup T
    Proc Soc Exp Biol Med; 1969 Mar; 130(3):811-3. PubMed ID: 5773672
    [No Abstract]   [Full Text] [Related]  

  • 5. [Studies of activators and inhibitors of fibrinolysis in lichen planus].
    Lotti T; Fabbri P
    G Ital Dermatol Venereol; 1984; 119(2):97-103. PubMed ID: 6539754
    [No Abstract]   [Full Text] [Related]  

  • 6. Desmoteplase-mediated plasminogen activation and clot lysis are inhibited by the lysine analogue tranexamic acid.
    Niego B; Horvath A; Coughlin PB; Pugsley MK; Medcalf RL
    Blood Coagul Fibrinolysis; 2008 Jun; 19(4):322-4. PubMed ID: 18469556
    [No Abstract]   [Full Text] [Related]  

  • 7. Recent progress in fibrinolysis.
    Mannucci PM; Minetti D; Mari D
    Southeast Asian J Trop Med Public Health; 1979 Sep; 10(3):328-35. PubMed ID: 160079
    [No Abstract]   [Full Text] [Related]  

  • 8. The role of hemostasis and fibrinolysis in the metastatic spread of cancer.
    Markus G
    Semin Thromb Hemost; 1984 Jan; 10(1):61-70. PubMed ID: 6538342
    [No Abstract]   [Full Text] [Related]  

  • 9. The biochemistry of the fibrinolytic enzyme system in man.
    Rickli EE
    Angiologica; 1968; 5(2):66-79. PubMed ID: 4232516
    [No Abstract]   [Full Text] [Related]  

  • 10. The inhibition of tissue plasminogen activator and urokinase-induced fibrinolysis by some natural proteinase inhibitors and by plasma and serum from normal and pregnant subjects.
    Thorsen S
    Scand J Clin Lab Invest; 1973 Jan; 31(1):51-9. PubMed ID: 4687777
    [No Abstract]   [Full Text] [Related]  

  • 11. [Thromboembolic complications, the coagulation and fibrinolytic blood system in heart defects with pronounced circulatory insufficiency].
    Gritsiuk AI
    Kardiologiia; 1969 Sep; 9(9):21-8. PubMed ID: 4244024
    [No Abstract]   [Full Text] [Related]  

  • 12. Immunologic aspects of plasminogen.
    Sachs V; Szirmai E
    Angiology; 1970 Jan; 21(1):1-4. PubMed ID: 4984359
    [No Abstract]   [Full Text] [Related]  

  • 13. Comparative studies of fibrinolytic inhibitors in vitro.
    Maki M; Beller FK
    Thromb Diath Haemorrh; 1966 Dec; 16(3):668-86. PubMed ID: 4231539
    [No Abstract]   [Full Text] [Related]  

  • 14. [Comparative studies on the antifibrinolytic effect (in vitro and in vivo) of t-AMCHA, phenyl-t-AMCHA, trasylol].
    Moriguchi S
    Nihon Seirigaku Zasshi; 1971; 33(6):355-63. PubMed ID: 5315192
    [No Abstract]   [Full Text] [Related]  

  • 15. Natural inhibitors of fibrinolysis.
    Collen D
    J Clin Pathol Suppl (R Coll Pathol); 1980; 14():24-30. PubMed ID: 6448870
    [No Abstract]   [Full Text] [Related]  

  • 16. Synthetic inhibitors of fibrinolysis: in vitro and in vivo mode of action.
    Okamoto S; Oshiba S; Mihara H; Okamoto U
    Ann N Y Acad Sci; 1968 Jun; 146(2):414-29. PubMed ID: 5254270
    [No Abstract]   [Full Text] [Related]  

  • 17. Demonstration of low content of fibrinolytic inhibitors in individuals with high fibrinolytic capacity.
    Hedner U; Nilsson IM; Jacobsen CD
    Scand J Clin Lab Invest; 1970 Jun; 25(4):329-36. PubMed ID: 4247664
    [No Abstract]   [Full Text] [Related]  

  • 18. Studies on the mechanism of action of synthetic antifibrinolytics. A comparison with the action of derivatives of benzamidine on the fibrinolytic process.
    Landmann H
    Thromb Diath Haemorrh; 1973 May; 29(2):253-75. PubMed ID: 4271586
    [No Abstract]   [Full Text] [Related]  

  • 19. The response of the fibrinolytic system in trauma.
    Risberg B
    Acta Chir Scand Suppl; 1985; 522():245-71. PubMed ID: 3893000
    [No Abstract]   [Full Text] [Related]  

  • 20. [Role of the initial level of plasminogen activator in changes in fibrinolysis].
    Andreenko GV; Liutova LV; Karabasova MA; Podorol'skaia LV; Serebriakova TN
    Fiziol Zh SSSR Im I M Sechenova; 1983 Mar; 69(3):380-5. PubMed ID: 6343132
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.